Mark W. Elrod
Corporate Officer/Principal at Kowa Pharmaceuticals America, Inc.
Profile
Mark W.
Elrod is currently the SVP-Medical Education & Sales Training at Kowa Pharmaceuticals America, Inc. He previously worked as the Vice President-Sales at Flamel Technologies SA.
Mark W. Elrod active positions
Companies | Position | Start |
---|---|---|
Kowa Pharmaceuticals America, Inc.
Kowa Pharmaceuticals America, Inc. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL. | Corporate Officer/Principal | - |
Former positions of Mark W. Elrod
Companies | Position | End |
---|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Sales & Marketing | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Kowa Pharmaceuticals America, Inc.
Kowa Pharmaceuticals America, Inc. Pharmaceuticals: MajorHealth Technology Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL. | Health Technology |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
- Stock Market
- Insiders
- Mark W. Elrod